177 related articles for article (PubMed ID: 15795089)
1. Limited modulation of the transport activity of the human multidrug resistance proteins MRP1, MRP2 and MRP3 by nicotine glucuronide metabolites.
Létourneau IJ; Bowers RJ; Deeley RG; Cole SP
Toxicol Lett; 2005 May; 157(1):9-19. PubMed ID: 15795089
[TBL] [Abstract][Full Text] [Related]
2. Transport of ethinylestradiol glucuronide and ethinylestradiol sulfate by the multidrug resistance proteins MRP1, MRP2, and MRP3.
Chu XY; Huskey SE; Braun MP; Sarkadi B; Evans DC; Evers R
J Pharmacol Exp Ther; 2004 Apr; 309(1):156-64. PubMed ID: 14722317
[TBL] [Abstract][Full Text] [Related]
3. Efflux transport of nicotine, cotinine and trans-3'-hydroxycotinine glucuronides by human hepatic transporters.
Järvinen E; Sjöstedt N; Koenderink JB; Kidron H; Finel M
Basic Clin Pharmacol Toxicol; 2019 Dec; 125(6):490-498. PubMed ID: 31237077
[TBL] [Abstract][Full Text] [Related]
4. Modulation of human multidrug resistance protein (MRP) 1 (ABCC1) and MRP2 (ABCC2) transport activities by endogenous and exogenous glutathione-conjugated catechol metabolites.
Slot AJ; Wise DD; Deeley RG; Monks TJ; Cole SP
Drug Metab Dispos; 2008 Mar; 36(3):552-60. PubMed ID: 18079363
[TBL] [Abstract][Full Text] [Related]
5. Transport of the beta -O-glucuronide conjugate of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) by the multidrug resistance protein 1 (MRP1). Requirement for glutathione or a non-sulfur-containing analog.
Leslie EM; Ito K; Upadhyaya P; Hecht SS; Deeley RG; Cole SP
J Biol Chem; 2001 Jul; 276(30):27846-54. PubMed ID: 11375986
[TBL] [Abstract][Full Text] [Related]
6. Structural determinants of substrate specificity differences between human multidrug resistance protein (MRP) 1 (ABCC1) and MRP3 (ABCC3).
Grant CE; Gao M; DeGorter MK; Cole SP; Deeley RG
Drug Metab Dispos; 2008 Dec; 36(12):2571-81. PubMed ID: 18775981
[TBL] [Abstract][Full Text] [Related]
7. Mutational analysis of a highly conserved proline residue in MRP1, MRP2, and MRP3 reveals a partially conserved function.
Létourneau IJ; Slot AJ; Deeley RG; Cole SP
Drug Metab Dispos; 2007 Aug; 35(8):1372-9. PubMed ID: 17494643
[TBL] [Abstract][Full Text] [Related]
8. Transport of amphipathic anions by human multidrug resistance protein 3.
Zeng H; Liu G; Rea PA; Kruh GD
Cancer Res; 2000 Sep; 60(17):4779-84. PubMed ID: 10987286
[TBL] [Abstract][Full Text] [Related]
9. Construction of triple-transfected cells [organic anion-transporting polypeptide (OATP) 1B1/multidrug resistance-associated protein (MRP) 2/MRP3 and OATP1B1/MRP2/MRP4] for analysis of the sinusoidal function of MRP3 and MRP4.
Hirouchi M; Kusuhara H; Onuki R; Ogilvie BW; Parkinson A; Sugiyama Y
Drug Metab Dispos; 2009 Oct; 37(10):2103-11. PubMed ID: 19628752
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the transport properties of cloned rat multidrug resistance-associated protein 3 (MRP3).
Hirohashi T; Suzuki H; Sugiyama Y
J Biol Chem; 1999 May; 274(21):15181-5. PubMed ID: 10329726
[TBL] [Abstract][Full Text] [Related]
11. Selectivity in the Efflux of Glucuronides by Human Transporters: MRP4 Is Highly Active toward 4-Methylumbelliferone and 1-Naphthol Glucuronides, while MRP3 Exhibits Stereoselective Propranolol Glucuronide Transport.
Järvinen E; Troberg J; Kidron H; Finel M
Mol Pharm; 2017 Oct; 14(10):3299-3311. PubMed ID: 28850245
[TBL] [Abstract][Full Text] [Related]
12. Substrates and inhibitors of human multidrug resistance associated proteins and the implications in drug development.
Zhou SF; Wang LL; Di YM; Xue CC; Duan W; Li CG; Li Y
Curr Med Chem; 2008; 15(20):1981-2039. PubMed ID: 18691054
[TBL] [Abstract][Full Text] [Related]
13. Differential modulation of the human liver conjugate transporters MRP2 and MRP3 by bile acids and organic anions.
Bodo A; Bakos E; Szeri F; Varadi A; Sarkadi B
J Biol Chem; 2003 Jun; 278(26):23529-37. PubMed ID: 12704183
[TBL] [Abstract][Full Text] [Related]
14. Cysteinyl Leukotriene Receptor 1/2 Antagonists Nonselectively Modulate Organic Anion Transport by Multidrug Resistance Proteins (MRP1-4).
Csandl MA; Conseil G; Cole SP
Drug Metab Dispos; 2016 Jun; 44(6):857-66. PubMed ID: 27068271
[TBL] [Abstract][Full Text] [Related]
15. Interplay between MRP inhibition and metabolism of MRP inhibitors: the case of curcumin.
Wortelboer HM; Usta M; van der Velde AE; Boersma MG; Spenkelink B; van Zanden JJ; Rietjens IM; van Bladeren PJ; Cnubben NH
Chem Res Toxicol; 2003 Dec; 16(12):1642-51. PubMed ID: 14680379
[TBL] [Abstract][Full Text] [Related]
16. Function and expression of multidrug resistance-associated protein family in human colon adenocarcinoma cells (Caco-2).
Hirohashi T; Suzuki H; Chu XY; Tamai I; Tsuji A; Sugiyama Y
J Pharmacol Exp Ther; 2000 Jan; 292(1):265-70. PubMed ID: 10604957
[TBL] [Abstract][Full Text] [Related]
17. ATP-dependent transport of bile salts by rat multidrug resistance-associated protein 3 (Mrp3).
Hirohashi T; Suzuki H; Takikawa H; Sugiyama Y
J Biol Chem; 2000 Jan; 275(4):2905-10. PubMed ID: 10644759
[TBL] [Abstract][Full Text] [Related]
18. Multidrug resistance protein 4 (MRP4/ABCC4) mediates efflux of bimane-glutathione.
Bai J; Lai L; Yeo HC; Goh BC; Tan TM
Int J Biochem Cell Biol; 2004 Feb; 36(2):247-57. PubMed ID: 14643890
[TBL] [Abstract][Full Text] [Related]
19. Interactions of the human multidrug resistance proteins MRP1 and MRP2 with organic anions.
Bakos E; Evers R; Sinkó E; Váradi A; Borst P; Sarkadi B
Mol Pharmacol; 2000 Apr; 57(4):760-8. PubMed ID: 10727523
[TBL] [Abstract][Full Text] [Related]
20. Expression of the multidrug resistance proteins MRP2 and MRP3 in human hepatocellular carcinoma.
Nies AT; König J; Pfannschmidt M; Klar E; Hofmann WJ; Keppler D
Int J Cancer; 2001 Nov; 94(4):492-9. PubMed ID: 11745434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
